Cite
[A Case of Advanced Recurrent Rectal Cancer Successfully Treated by Rechallenge Therapy with an Anti-Epidermal Growth Factor Receptor(EGFR)Drug].
MLA
Sakuma, Takashi, et al. “[A Case of Advanced Recurrent Rectal Cancer Successfully Treated by Rechallenge Therapy with an Anti-Epidermal Growth Factor Receptor(EGFR)Drug].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 50, no. 13, Dec. 2023, pp. 1504–06. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=38303322&authtype=sso&custid=ns315887.
APA
Sakuma, T., Shibutani, M., Fukuoka, T., Kasashima, H., Nishiyama, M., Fukui, Y., Natsuki, S., Nishiyama, T., Maruo, K., Miki, Y., Yoshii, M., Tamura, T., Toyokawa, T., Lee, S., & Maeda, K. (2023). [A Case of Advanced Recurrent Rectal Cancer Successfully Treated by Rechallenge Therapy with an Anti-Epidermal Growth Factor Receptor(EGFR)Drug]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 50(13), 1504–1506.
Chicago
Sakuma, Takashi, Masatsune Shibutani, Tatsunari Fukuoka, Hiroaki Kasashima, Masaki Nishiyama, Yasuhiro Fukui, Seiji Natsuki, et al. 2023. “[A Case of Advanced Recurrent Rectal Cancer Successfully Treated by Rechallenge Therapy with an Anti-Epidermal Growth Factor Receptor(EGFR)Drug].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 50 (13): 1504–6. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=38303322&authtype=sso&custid=ns315887.